| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 4 | |
| #3 | Canada | 4 | |
| #4 | China | 4 | |
| #5 | Republic of Korea | 4 | |
| #6 | EPO (European Patent Office) | 3 | |
| #7 | Israel | 3 | |
| #8 | Japan | 2 | |
| #9 | Brazil | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Diagnosis and surgery | |
| #4 | Measuring microorganism processes | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Durham Lynn | 28 |
| #2 | Lynn Durham | 3 |
| #3 | Hyvelin Jean-Marc | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020094748A1 | Metabolic profiling for the diagnosis of a subset of idiopathic autism spectrum disorder patients, asd phenotype 1 | |
| CN111511407A | Treatment of ASD subtypes | |
| AU2018359720A1 | Biomarker assay for use in monitoring autism | |
| CA3023014A1 | Pharmaceutical composition for treatment of autism |